Radionuclide Imaging of Inflammation in Atheroma

[1]  Vinay Kumar,et al.  Acute and Chronic Inflammation , 2010 .

[2]  Han Liu,et al.  Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[3]  M. Gidlund,et al.  Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. , 2009, International journal of cardiology.

[4]  C. Reutelingsperger,et al.  PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[5]  N. Wong,et al.  Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. , 2008, Journal of the American College of Cardiology.

[6]  F. Blankenberg,et al.  Prolonged High-Fat Feeding Enhances Aortic 18F-FDG and 99mTc-Annexin A5 Uptake in Apolipoprotein E-Deficient and Wild-Type C57BL/6J Mice , 2008, Journal of Nuclear Medicine.

[7]  Pankaj Garg,et al.  Arithmetic of vulnerable plaques for noninvasive imaging , 2008, Nature Clinical Practice Cardiovascular Medicine.

[8]  Sameer Bansilal,et al.  Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.

[9]  C. Reutelingsperger,et al.  Annexin A5: an imaging biomarker of cardiovascular risk , 2008, Basic Research in Cardiology.

[10]  Y. Castier,et al.  Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.

[11]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[12]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[13]  Ora Israel,et al.  Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  M. Mäyränpää,et al.  Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion , 2006, Coronary artery disease.

[15]  P. Weissberg,et al.  Radionuclide imaging for the detection of inflammation in vulnerable plaques. , 2006, Journal of the American College of Cardiology.

[16]  A. Freiman,et al.  Association of vascular 18F-FDG uptake with vascular calcification. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Ahmed Tawakol,et al.  Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[18]  Ora Israel,et al.  Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[20]  H. Watabe,et al.  (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  R. Virmani,et al.  Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque , 2003, Circulation.

[22]  Yuji Nakamoto,et al.  Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. , 2003, Radiology.

[23]  B. Osterud,et al.  Role of monocytes in atherogenesis. , 2003, Physiological reviews.

[24]  A. Dyer,et al.  Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .

[25]  P. Wilson,et al.  34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? , 2003, Journal of the American College of Cardiology.

[26]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[27]  A. Alavi,et al.  18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.

[28]  H. Strauss,et al.  Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study , 2001, Circulation.

[29]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[30]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[31]  R. Virmani,et al.  Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. , 2000, The American journal of pathology.

[32]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Ignasi Carrió,et al.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[34]  V. Fuster,et al.  Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  G. Ronga,et al.  Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. , 1996, Atherosclerosis.

[36]  P. V. van Rijk,et al.  Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  V. Torchilin,et al.  Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. , 1995, Circulation.

[38]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  A. Fischman,et al.  Imaging Human Atherosclerosis with 99mTc‐labeled Low Density Lipoproteins , 1988, Arteriosclerosis.

[40]  A M Lees,et al.  External imaging of human atherosclerosis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  M. Welch,et al.  SCINTIGRAPHIC DETECTION OF ATHEROSCLEROTIC LESIONS AND VENOUS THROMBI IN MAN BY INDIUM-111-LABELLED AUTOLOGOUS PLATELETS , 1978, The Lancet.

[42]  N. Simmons,et al.  Letter: Fish and shellfish hygiene. , 1975, Lancet.